FREE Account Opening + No Clearing Fees
Loading...

Innova Captab IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 10 0 2 0 1
% 76.92 0.00 15.38 0.00 7.69

Innova Captab IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for Innova Captab IPO is 44. Their analysis recommends Avoid, however active risk seekers can try for the IPO.

Reviewer Rating Score Rating
Capital Market 44 Avoid, however active risk seekers can try

Innova Captab IPO Review by Dilip Davda (Apply)

[Dilip Davda]  The company is a branded generic pharmaceutical products manufacturer for the domestic and international markets. It has posted growth in its top and bottom lines. Recent acquisition of Sharon Bio by the company augurs well for its synergistic growth plans. It is also gearing for new product portfolio with its upcoming new plant at Jammu. Based on FY24 annualized earnings, the issue appears fully priced, but it is poised for bright prospects post expansion. Investors may park funds for the medium to long term rewards. Read detail review...

Innova Captab IPO Peer Comparison

Innova Captab Limited peer comparison with similar listed entities. (As on March 31, 2023)

Company NameEPS (Basic)EPS (Diluted)NAV (per share) (Rs)P/E (x)RoNW (%)Closing price as on period endedP/BV RatioFinancial statements
Innova Captab Limited14.1614.1657.6024.58Consolidated
Torrent Pharmaceuticals Limited36.7936.79182.9757.6120.112,119.6511.58Consolidated
Laurus Labs Limited14.6914.6474.9225.5319.74373.704.99Consolidated
Ajanta Pharma Limited45.8945.89267.4142.9117.361,969.157.36Consolidated
J. B. Chemicals and Pharmaceuticals Limited53.0052.34320.3628.6116.541,497.304.67Consolidated
NATCO Pharma Limited39.1839.18264.2119.9014.84779.552.95Consolidated
Eris Lifesciences Limited28.1028.07160.8533.0117.10926.705.76Consolidated
Indoco Remedies Limited15.4415.42111.5822.7413.83350.703.14Consolidated
Suven Pharmaceuticals Limited16.1616.1668.1637.1323.70600.058.80Consolidated
Windlas Biotech Limited19.7019.70192.0222.0410.61434.252.26Consolidated

Note:

All the financial information for listed industry peers mentioned above is on a consolidated basis and is sourced from the annual reports as available of the respective company for the year ended March 31, 2023. The information for Innova Captab Limited has been sourced from the Restated Consolidated Financial Information for the year ended March 31, 2023.

The financial parameters above are not reclassified by CRISIL and taken as reported by players.

Closing Price has been taken as of November 21, 2023

Hence, the comparison should not be made with the tables in the rest of the competitive section of the "Industry Overview" section.

The financial parameters are calculated as described below:

Net worth = Equity share capital + Other equity-capital reserves

NAV per share = Net worth / Number of equity shares outstanding R

eturn on net worth = PAT / Net worth


Innova Captab IPO Review by Members

Innova Captab IPO Reviews, analysis and views by popular members. Read Innova Captab Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Innova Captab IPO Review Summary by Members

Review By Apply May Apply Neutral Avoid
Count 0 1 0 0
% 0.00 100.00 0.00 0.00
Clear Search
Member Review
Ankit Dhakad

May Apply for Listing Gain at Cut-off Price

Apply for small listinga gains.

I Like It. 1

December 24, 2023 6:37:21 PM

Post Recommendation Manage Recommendations

Note:

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.